Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carmen Sánchez-Bacaicoa"'
Autor:
Clara Costo-Muriel, Julián F. Calderón-García, Sergio Rico-Martín, Javier Galán-González, Guillermo Escudero-Sánchez, Carmen Sánchez-Bacaicoa, Francisco J. Rodríguez-Velasco, Esperanza Santano-Mogena, César Fonseca, Juan F. Sánchez Muñoz-Torrero
Publikováno v:
Frontiers in Nutrition, Vol 10 (2023)
IntroductionOver the last few years, novel anthropometric indices have been developed as an alternative to body mass index (BMI) and other traditional anthropometric measurements to enhance the estimate of fat proportion and its relationship to a fut
Externí odkaz:
https://doaj.org/article/443c4dba02494988b536155cb981b4bc
Autor:
Clara Costo-Muriel, Julián F. Calderón-García, Sergio Rico-Martín, Carmen Sánchez-Bacaicoa, Guillermo Escudero-Sánchez, Javier Galán-González, Francisco J. Rodríguez-Velasco, Juan F. Sánchez Muñoz-Torrero
Publikováno v:
Current problems in cardiology.
Novel anthropometric indices have been proposed as an alternative to body mass index (BMI) and waist circumference (WC) to determine visceral adipose tissue and body mass. Little is known about the relationship of these new anthropometric indices to
Autor:
Guillermo Escudero-Sánchez, Sergio Rico-Martín, Carmen Sánchez-Bacaicoa, Clara Costo, Javier Galán-González, Julián F. Calderón-García, Juan D. Pedrera-Zamorano, Juan F. Sánchez Muñoz-Torrero
Publikováno v:
Current Problems in Cardiology. 48:101530
The effects of maintaining all classical, vascular risk factors on target among patients with stabilized atherosclerotic cardiovascular disease (ASCVD) are uncertain. Factores de Riesgo y ENfermedad Arterial (FRENA) was a prospective registry of cons
Autor:
Carmen, Sánchez-Bacaicoa, Javier, Galán, Carlos, Guijarro, Sergio, Rico-Martín, Manuel, Monreal, Julián F, Calderón-García, Eduardo, Aguilar-Cortés, Juan F, Sánchez Muñoz-Torrero, M, Yeste
Publikováno v:
European journal of clinical investigationREFERENCES. 52(5)
Clinical trials have shown that intensive low-density lipoprotein cholesterol (LDL-C) lowering improves cardiovascular outcomes among patients with atherosclerotic cardiovascular disease (ASCVD), but data are limited in real clinical practice, partic